Resonance Health Ltd (AU:RHT) — Market Cap & Net Worth
Market Cap & Net Worth: Resonance Health Ltd (RHT)
Resonance Health Ltd (AU:RHT) has a market capitalization of $20.99 Million (AU$29.67 Million) as of August 1, 2026. Listed on the AU stock exchange, this Australia-based company holds position #24905 globally and #1033 in its home market, demonstrating a 36.17% increase in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Resonance Health Ltd's stock price AU$0.06 by its total outstanding shares 477120233 (477.12 Million). See how much does Resonance Health Ltd reinvest in capital to understand how much of operating cash flow is reinvested back into capital assets.
Resonance Health Ltd Market Cap History: 2015 to 2026
Resonance Health Ltd's market capitalization history from 2015 to 2026. Data shows growth from $8.44 Million to $21.61 Million (6.33% CAGR).
Resonance Health Ltd Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Resonance Health Ltd's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
1.49x
Resonance Health Ltd's market cap is 1.49 times its annual revenue
Latest Price to Earnings (P/E) Ratio
N/A
P/E ratio not applicable due to negative or zero earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2016 | $8.78 Million | $2.55 Million | -$384.00K | 3.44x | N/A |
| 2017 | $7.43 Million | $2.48 Million | -$304.00K | 2.99x | N/A |
| 2018 | $20.26 Million | $2.90 Million | $224.62K | 6.99x | 90.18x |
| 2019 | $75.96 Million | $3.62 Million | $1.27 Million | 20.95x | 59.81x |
| 2020 | $81.02 Million | $3.67 Million | -$715.00K | 22.09x | N/A |
| 2021 | $47.26 Million | $3.78 Million | $585.86K | 12.51x | 80.67x |
| 2022 | $20.26 Million | $3.83 Million | -$1.14 Million | 5.29x | N/A |
| 2023 | $20.26 Million | $4.40 Million | -$780.00K | 4.60x | N/A |
| 2024 | $17.55 Million | $8.59 Million | $169.30K | 2.04x | 103.69x |
| 2025 | $16.54 Million | $11.07 Million | -$1.73 Million | 1.49x | N/A |
Competitor Companies of RHT by Market Capitalization
Companies near Resonance Health Ltd in the global market cap rankings as of August 1, 2026.
Key companies related to Resonance Health Ltd by market ranking:
- Veeva Systems Inc Class A (NYSE:VEEV): Ranked #980 globally with a market cap of $27.24 Billion USD.
- Pro Medicus Ltd (AU:PME): Ranked #1931 globally with a market cap of $11.99 Billion USD ( AU$16.95 Billion AUD).
- BrightSpring Health Services, Inc. Common Stock (NASDAQ:BTSG): Ranked #2123 globally with a market cap of $10.63 Billion USD.
- Tempus AI, Inc. Class A Common Stock (NASDAQ:TEM): Ranked #2675 globally with a market cap of $7.62 Billion USD.
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #980 | Veeva Systems Inc Class A | NYSE:VEEV | $27.24 Billion | $203.78 |
| #1931 | Pro Medicus Ltd | AU:PME | $11.99 Billion | AU$162.21 |
| #2123 | BrightSpring Health Services, Inc. Common Stock | NASDAQ:BTSG | $10.63 Billion | $59.71 |
| #2675 | Tempus AI, Inc. Class A Common Stock | NASDAQ:TEM | $7.62 Billion | $43.87 |
Resonance Health Ltd Historical Marketcap From 2015 to 2026
Between 2015 and today, Resonance Health Ltd's market cap moved from $8.44 Million to $ 21.61 Million, with a yearly change of 6.33%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | AU$21.61 Million | +30.61% |
| 2025 | AU$16.54 Million | -5.77% |
| 2024 | AU$17.55 Million | -13.33% |
| 2023 | AU$20.26 Million | 0.00% |
| 2022 | AU$20.26 Million | -57.14% |
| 2021 | AU$47.26 Million | -41.67% |
| 2020 | AU$81.02 Million | +6.67% |
| 2019 | AU$75.96 Million | +275.00% |
| 2018 | AU$20.26 Million | +172.73% |
| 2017 | AU$7.43 Million | -15.38% |
| 2016 | AU$8.78 Million | +4.00% |
| 2015 | AU$8.44 Million | -- |
End of Day Market Cap According to Different Sources
On Aug 1st, 2026 the market cap of Resonance Health Ltd was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $20.99 Million USD |
| MoneyControl | $20.99 Million USD |
| MarketWatch | $20.99 Million USD |
| marketcap.company | $20.99 Million USD |
| Reuters | $20.99 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About Resonance Health Ltd
Resonance Health Limited, a healthcare technology and services company, designs, develops, manufactures, and commercializes software-as-medical devices (SaMD) in the Asia Pacific, North America, Europe, the Middle East, and Africa. It operates through SaMD, Resonance Clinical, and TrialsWest segments. The company offers FerriScan, a non-invasive MRI based solution for quantifying liver iron conce… Read more